Country-Specific Barriers to Direct-to-Patient (DTP) Implementation in Clinical Trials
Country-Specific Barriers to Direct-to-Patient (DTP) Implementation in Clinical Trials Navigating Country-Specific Barriers in Implementing DTP Models for Clinical Trials As decentralized clinical trials (DCTs) gain global momentum, Direct-to-Patient (DTP) drug delivery models are transforming how investigational products reach participants. However, implementing DTP models across different countries is not uniform. Regulatory, logistical, cultural, and legal variances…
Read More “Country-Specific Barriers to Direct-to-Patient (DTP) Implementation in Clinical Trials” »